GREENWICH, Conn. & WALNUT CREEK, Calif. – Amulet Capital Partners, LP, a leading middle-market private equity firm exclusively dedicated to the healthcare sector, has announced the successful closing of its Amulet Capital Fund III (Fund III). The fund closed with approximately $1.2 billion in capital commitments, significantly exceeding its initial target. This achievement underscores the strong investor confidence in Amulet Capital Partners and its focused investment strategy within the healthcare industry.
Fund III attracted commitments from a diverse group of global institutional investors. This includes state and corporate pension funds, endowments, foundations, and family offices, highlighting the broad appeal of Amulet Capital Partners‘ investment approach. With the closing of Fund III, Amulet Capital Partners now manages approximately $2.7 billion in assets, solidifying its position as a significant player in healthcare private equity.
Building upon its established value-oriented and thesis-driven investment strategy, Amulet Capital Partners will utilize Fund III to continue partnering with robust businesses operating within high-growth subsectors of the healthcare ecosystem. These key areas include life sciences outsourcing, healthcare providers, and payor and payor services. The firm’s flexible and creative approach to structuring investments allows Amulet Capital Partners to effectively collaborate with management teams. This partnership approach is central to executing a shared vision focused on generating substantial long-term value.
Ramsey Frank, President and Managing Partner of Amulet Capital Partners, expressed gratitude for the strong investor support. “We are grateful to have received such strong support from our existing and new investors and are pleased to have closed Fund III significantly above target,” Frank stated. He further emphasized the consistency of the firm’s approach, “This marks the third consecutive above-target raise for our firm, which we view as a testament to our consistent investment philosophy and the strength of the value-creation framework we’ve built and successfully implemented across our portfolio consistently throughout cycles.”
Jay Rose, Managing Partner at Amulet Capital Partners, also commented on the successful capital raise and the firm’s strategic focus. “This successful capital raise reflects the deep expertise of our team, network and track record of delivering positive outcomes,” Rose noted. He highlighted the opportunities within their chosen sectors, “We believe the unique – and often underinvested – subsectors we’ve identified represent significant opportunity for Fund III. We are excited to continue strategically deploying capital to help build best-in-class businesses and drive meaningful change and innovation for patients, physicians and the broader healthcare landscape across the country.”
Fund III has already made two significant platform investments, demonstrating Amulet Capital Partners’ proactive approach. These include partnerships with:
- minds + assembly: A full-service, design-centric agency and commercialization platform serving the pharmaceutical, biotech, and digital health industries.
- Alliance Clinical Network: A leading comprehensive clinical platform supporting patients, pharmaceutical sponsors, and CROs across various clinical areas, including dermatology, gastroenterology, neurology, pain, vaccines, and women’s health.
Capstone Partners, a Mizuho Company, served as the exclusive placement agent for Fund III, and Kirkland & Ellis LLP provided legal counsel to Amulet Capital Partners.
About Amulet Capital Partners
Amulet Capital Partners is a middle-market private equity firm strategically located in Greenwich, CT, and Walnut Creek, CA. The firm operates exclusively within the healthcare sector, pursuing privately negotiated investments in healthcare companies with the goal of achieving long-term capital appreciation. Amulet Capital Partners targets segments within healthcare that exhibit the most attractive long-term fundamentals, with typical investment sizes ranging from $50 million to $150 million. For more detailed information, please visit www.amuletcapital.com.
